Skip to main content
Top
Published in: Inflammation 4/2022

21-02-2022 | Crohn's Disease | Original Article

MEFV and NLRP3 Inflammasome Expression Is Attributed to Immature Macrophages and Correlates with Serum Inflammatory Proteins in Crohn´s Disease Patients

Authors: Frida Gorreja, Charles Caër, Stephen T. A. Rush, Sophia K. Forsskål, Anetta Härtlova, Maria K. Magnusson, Elinor Bexe Lindskog, Lars G. Börjesson, Mattias Block, Mary Jo Wick

Published in: Inflammation | Issue 4/2022

Login to get access

Abstract

Inflammasomes are intracellular protein complexes whose activation results in proinflammatory cytokines. Inflammasomes are implicated in Crohn´s disease (CD) pathogenesis, yet the contribution of inflammasomes in intestinal epithelial cells (IECs) versus lamina propria (LP) macrophages is poorly understood. Whether inflammasome expression in intestinal tissue reflects the serum inflammatory protein profile of patients is also not known. We aimed to determine the intestinal cell types where inflammasome expression is increased in CD and if they correlate with the serum protein profile. RT-PCR and NanoString nCounter technology were used to characterize inflammasome gene expression in CD patients and controls. The mucosa, LP and IEC cell fractions and FACS-sorted cells were analyzed. Proximity extension assay with a 92-protein panel was used to determine the serum inflammatory protein profile. Compositional analysis was used to correlate ileum inflammasome gene expression with intestinal mononuclear phagocyte populations. We show that NLRP3 and MEFV inflammasome sensors and downstream effector expression including IL-1β are increased in inflamed mucosa of IBD patients and correlate with disease activity. Inflammasome gene expression increased with the abundance of immature intestinal macrophages, and increased IL-1β released by CD LP cells correlated with immature macrophage frequency. Inflammasome gene expression was also increased in circulating monocytes, the precursors of immature intestinal macrophages. Finally, the serum inflammatory profile of CD patients correlates with ileal expression of genes related to NLRP3 and MEFV inflammasomes. Overall, we show that MEFV and NLRP3 inflammasome expression in CD intestine is attributed to the accumulation of immature macrophages and correlates with serum inflammatory proteins.
Appendix
Available only for authorised users
Literature
1.
go back to reference de Souza, H.S., and C. Fiocchi. 2016. Immunopathogenesis of IBD: Current state of the art. Nature Reviews: Gastroenterology & Hepatology 13: 13–27. de Souza, H.S., and C. Fiocchi. 2016. Immunopathogenesis of IBD: Current state of the art. Nature Reviews: Gastroenterology & Hepatology 13: 13–27.
2.
go back to reference Neurath, M.F. 2019. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nature Immunology 20: 970–979.CrossRef Neurath, M.F. 2019. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nature Immunology 20: 970–979.CrossRef
3.
go back to reference Caër, C., and M.J. Wick. 2020. Human intestinal mononuclear phagocytes in health and inflammatory bowel disease. Frontiers in Immunology 11: 410.CrossRef Caër, C., and M.J. Wick. 2020. Human intestinal mononuclear phagocytes in health and inflammatory bowel disease. Frontiers in Immunology 11: 410.CrossRef
4.
go back to reference Magnusson, M.K., S.F. Brynjolfsson, A. Dige, H. Uronen-Hansson, L.G. Borjesson, J.L. Bengtsson, et al. 2016. Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation. Mucosal Immunology 9: 171–182.CrossRef Magnusson, M.K., S.F. Brynjolfsson, A. Dige, H. Uronen-Hansson, L.G. Borjesson, J.L. Bengtsson, et al. 2016. Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation. Mucosal Immunology 9: 171–182.CrossRef
5.
go back to reference Chan, A.H., and K. Schroder. 2020. Inflammasome signaling and regulation of interleukin-1 family cytokines. Journal of Experimental Medicine 217. Chan, A.H., and K. Schroder. 2020. Inflammasome signaling and regulation of interleukin-1 family cytokines. Journal of Experimental Medicine 217.
6.
go back to reference Friedrich, M., M. Pohin, and F. Powrie. 2019. Cytokine networks in the pathophysiology of inflammatory bowel disease. Immunity 50: 992–1006.CrossRef Friedrich, M., M. Pohin, and F. Powrie. 2019. Cytokine networks in the pathophysiology of inflammatory bowel disease. Immunity 50: 992–1006.CrossRef
7.
go back to reference Mao, L., A. Kitani, W. Strober, and I.J. Fuss. 2018. The role of NLRP3 and IL-1β in the pathogenesis of inflammatory bowel disease. Frontiers in Immunology 9: 2566.CrossRef Mao, L., A. Kitani, W. Strober, and I.J. Fuss. 2018. The role of NLRP3 and IL-1β in the pathogenesis of inflammatory bowel disease. Frontiers in Immunology 9: 2566.CrossRef
8.
go back to reference Ranson, N., M. Veldhuis, B. Mitchell, S. Fanning, A.L. Cook, D. Kunde, et al. 2018. Nod-like receptor pyrin-containing protein 6 (NLRP6) is up-regulated in ileal Crohn’s disease and differentially expressed in goblet cells. Cellular and Molecular Gastroenterology and Hepatology 6: 110-112.e118.CrossRef Ranson, N., M. Veldhuis, B. Mitchell, S. Fanning, A.L. Cook, D. Kunde, et al. 2018. Nod-like receptor pyrin-containing protein 6 (NLRP6) is up-regulated in ileal Crohn’s disease and differentially expressed in goblet cells. Cellular and Molecular Gastroenterology and Hepatology 6: 110-112.e118.CrossRef
9.
go back to reference Schnappauf, O., J.J. Chae, D.L. Kastner, and I. Aksentijevich. 2019. The pyrin inflammasome in health and disease. Frontiers in Immunology 10: 1745.CrossRef Schnappauf, O., J.J. Chae, D.L. Kastner, and I. Aksentijevich. 2019. The pyrin inflammasome in health and disease. Frontiers in Immunology 10: 1745.CrossRef
10.
go back to reference Sharma, D., A. Malik, C.S. Guy, R. Karki, P. Vogel, and T.D. Kanneganti. 2018. Pyrin inflammasome regulates tight junction integrity to restrict colitis and tumorigenesis. Gastroenterology:948–964.e948. Sharma, D., A. Malik, C.S. Guy, R. Karki, P. Vogel, and T.D. Kanneganti. 2018. Pyrin inflammasome regulates tight junction integrity to restrict colitis and tumorigenesis. Gastroenterology:948–964.e948.
11.
go back to reference Brynjolfsson, S.F., M.K. Magnusson, P.L. Kong, T. Jensen, J.L. Kuijper, K. Hakansson, et al. 2016. An antibody against triggering receptor expressed on myeloid cells 1 (TREM-1) dampens proinflammatory cytokine secretion by lamina propria cells from patients with IBD. Inflammatory Bowel Diseases 22: 1803–1811.CrossRef Brynjolfsson, S.F., M.K. Magnusson, P.L. Kong, T. Jensen, J.L. Kuijper, K. Hakansson, et al. 2016. An antibody against triggering receptor expressed on myeloid cells 1 (TREM-1) dampens proinflammatory cytokine secretion by lamina propria cells from patients with IBD. Inflammatory Bowel Diseases 22: 1803–1811.CrossRef
12.
go back to reference Caër, C., F. Gorreja, S.K. Forsskåhl, S.F. Brynjolfsson, L. Szeponik, M.K. Magnusson, et al. 2021. TREM-1+ macrophages define a pathogenic cell subset in the intestine of Crohn’s disease patients. Journal of Crohn’s & Colitis 15: 1346–1361.CrossRef Caër, C., F. Gorreja, S.K. Forsskåhl, S.F. Brynjolfsson, L. Szeponik, M.K. Magnusson, et al. 2021. TREM-1+ macrophages define a pathogenic cell subset in the intestine of Crohn’s disease patients. Journal of Crohn’s & Colitis 15: 1346–1361.CrossRef
13.
go back to reference Dumuid, D., Ž Pedišić, J. Palarea-Albaladejo, J.A. Martín-Fernández, K. Hron, and T. Olds. 2020. Compositional data analysis in time-use epidemiology: What, why, how. International Journal of Environmental Research and Public Health 17: 2220.CrossRef Dumuid, D., Ž Pedišić, J. Palarea-Albaladejo, J.A. Martín-Fernández, K. Hron, and T. Olds. 2020. Compositional data analysis in time-use epidemiology: What, why, how. International Journal of Environmental Research and Public Health 17: 2220.CrossRef
14.
go back to reference van den Boogaart, K., and R. Tolosana-Delgado. 2013. Analyzing compositional data with R. Heidelberg: Springer.CrossRef van den Boogaart, K., and R. Tolosana-Delgado. 2013. Analyzing compositional data with R. Heidelberg: Springer.CrossRef
17.
go back to reference Szklarczyk, D., A.L. Gable, D. Lyon, A. Junge, S. Wyder, J. Huerta-Cepas, et al. 2019. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research 47: D607-d613.CrossRef Szklarczyk, D., A.L. Gable, D. Lyon, A. Junge, S. Wyder, J. Huerta-Cepas, et al. 2019. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research 47: D607-d613.CrossRef
18.
go back to reference Hui, K.Y., H. Fernandez-Hernandez, J. Hu, A. Schaffner, N. Pankratz, N.Y. Hsu, et al. 2018. Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease. Science Translational Medicine 10. Hui, K.Y., H. Fernandez-Hernandez, J. Hu, A. Schaffner, N. Pankratz, N.Y. Hsu, et al. 2018. Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease. Science Translational Medicine 10.
19.
go back to reference Veldman-Jones, M.H., R. Brant, C. Rooney, C. Geh, H. Emery, C.G. Harbron, et al. 2015. Evaluating robustness and sensitivity of the NanoString technologies nCounter platform to enable multiplexed gene expression analysis of clinical samples. Cancer Research 75: 2587–2593.CrossRef Veldman-Jones, M.H., R. Brant, C. Rooney, C. Geh, H. Emery, C.G. Harbron, et al. 2015. Evaluating robustness and sensitivity of the NanoString technologies nCounter platform to enable multiplexed gene expression analysis of clinical samples. Cancer Research 75: 2587–2593.CrossRef
20.
go back to reference Man, S.M. 2018. Inflammasomes in the gastrointestinal tract: Infection, cancer and gut microbiota homeostasis. Nature Reviews: Gastroenterology & Hepatology 15: 721–737. Man, S.M. 2018. Inflammasomes in the gastrointestinal tract: Infection, cancer and gut microbiota homeostasis. Nature Reviews: Gastroenterology & Hepatology 15: 721–737.
21.
go back to reference Volk, J.K., E.E.L. Nystrom, S. van der Post, B.M. Abad, B.O. Schroeder, A. Johansson, et al. 2019. The NLRP6 inflammasome is not required for baseline colonic inner mucus layer formation or function. Journal of Experimental Medicine 216: 2602–2618.CrossRef Volk, J.K., E.E.L. Nystrom, S. van der Post, B.M. Abad, B.O. Schroeder, A. Johansson, et al. 2019. The NLRP6 inflammasome is not required for baseline colonic inner mucus layer formation or function. Journal of Experimental Medicine 216: 2602–2618.CrossRef
22.
go back to reference Bujko, A., N. Atlasy, O.J.B. Landsverk, L. Richter, S. Yaqub, R. Horneland, et al. 2018. Transcriptional and functional profiling defines human small intestinal macrophage subsets. Journal of Experimental Medicine 215: 441–458.CrossRef Bujko, A., N. Atlasy, O.J.B. Landsverk, L. Richter, S. Yaqub, R. Horneland, et al. 2018. Transcriptional and functional profiling defines human small intestinal macrophage subsets. Journal of Experimental Medicine 215: 441–458.CrossRef
23.
go back to reference Na, Y.R., M. Stakenborg, S.H. Seok, and G. Matteoli. 2019. Macrophages in intestinal inflammation and resolution: A potential therapeutic target in IBD Nature Reviews. Gastroenterology & Hepatology 19: 531–543. Na, Y.R., M. Stakenborg, S.H. Seok, and G. Matteoli. 2019. Macrophages in intestinal inflammation and resolution: A potential therapeutic target in IBD Nature Reviews. Gastroenterology & Hepatology 19: 531–543.
24.
go back to reference Rodrigues, T.S., K.S.G. de Sa, A.Y. Ishimoto, A. Becerra, S. Oliveira, L. Almeida, et al. 2021. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. Journal of Experimental Medicine 218:e20201707. Rodrigues, T.S., K.S.G. de Sa, A.Y. Ishimoto, A. Becerra, S. Oliveira, L. Almeida, et al. 2021. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. Journal of Experimental Medicine 218:e20201707.
25.
go back to reference Chen, P., G. Zhou, J. Lin, L. Li, Z. Zeng, M. Chen, et al. 2020. Serum biomarkers for inflammatory bowel disease. Frontiers in Medicine (Lausanne) 7: 123.CrossRef Chen, P., G. Zhou, J. Lin, L. Li, Z. Zeng, M. Chen, et al. 2020. Serum biomarkers for inflammatory bowel disease. Frontiers in Medicine (Lausanne) 7: 123.CrossRef
26.
go back to reference Magro, D.O., P.G. Kotze, C.A.R. Martinez, M.G. Camargo, D. Guadagnini, A.R. Calixto, et al. 2017. Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn’s disease. Intestinal Research 15: 352–357.CrossRef Magro, D.O., P.G. Kotze, C.A.R. Martinez, M.G. Camargo, D. Guadagnini, A.R. Calixto, et al. 2017. Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn’s disease. Intestinal Research 15: 352–357.CrossRef
27.
go back to reference Chen, K.W., B. Demarco, and P. Broz. 2020. Pannexin-1 promotes NLRP3 activation during apoptosis but is dispensable for canonical or noncanonical inflammasome activation. European Journal of Immunology 50: 170–177.CrossRef Chen, K.W., B. Demarco, and P. Broz. 2020. Pannexin-1 promotes NLRP3 activation during apoptosis but is dispensable for canonical or noncanonical inflammasome activation. European Journal of Immunology 50: 170–177.CrossRef
28.
go back to reference Licandro, G., H. Ling Khor, O. Beretta, J. Lai, H. Derks, F. Laudisi, et al. 2013. The NLRP3 inflammasome affects DNA damage responses after oxidative and genotoxic stress in dendritic cells. European Journal of Immunology 43: 2126–2137.CrossRef Licandro, G., H. Ling Khor, O. Beretta, J. Lai, H. Derks, F. Laudisi, et al. 2013. The NLRP3 inflammasome affects DNA damage responses after oxidative and genotoxic stress in dendritic cells. European Journal of Immunology 43: 2126–2137.CrossRef
29.
go back to reference Shi, C.S., and J.H. Kehrl. 2019. Bcl-2 regulates pyroptosis and necroptosis by targeting BH3-like domains in GSDMD and MLKL. Cell Death Discovery 5: 151.CrossRef Shi, C.S., and J.H. Kehrl. 2019. Bcl-2 regulates pyroptosis and necroptosis by targeting BH3-like domains in GSDMD and MLKL. Cell Death Discovery 5: 151.CrossRef
30.
go back to reference Zheng, M., E.P. Williams, R.K.S. Malireddi, R. Karki, B. Banoth, A. Burton, et al. 2020. Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection. Journal of Biological Chemistry 295: 14040–14052.CrossRef Zheng, M., E.P. Williams, R.K.S. Malireddi, R. Karki, B. Banoth, A. Burton, et al. 2020. Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection. Journal of Biological Chemistry 295: 14040–14052.CrossRef
31.
go back to reference Antonopoulos, C., H.M. Russo, C. El Sanadi, B.N. Martin, X. Li, W.J. Kaiser, et al. 2015. Caspase-8 as an effector and regulator of NLRP3 inflammasome signaling. Journal of Biological Chemistry 290: 20167–20184.CrossRef Antonopoulos, C., H.M. Russo, C. El Sanadi, B.N. Martin, X. Li, W.J. Kaiser, et al. 2015. Caspase-8 as an effector and regulator of NLRP3 inflammasome signaling. Journal of Biological Chemistry 290: 20167–20184.CrossRef
32.
go back to reference Tummers, B., L. Mari, C.S. Guy, B.L. Heckmann, D.A. Rodriguez, S. Rühl, et al. 2020. Caspase-8-dependent inflammatory responses are controlled by its adaptor, FADD, and necroptosis. Immunity 52: 994-1006.e1008.CrossRef Tummers, B., L. Mari, C.S. Guy, B.L. Heckmann, D.A. Rodriguez, S. Rühl, et al. 2020. Caspase-8-dependent inflammatory responses are controlled by its adaptor, FADD, and necroptosis. Immunity 52: 994-1006.e1008.CrossRef
33.
go back to reference Villani, A.C., M. Lemire, E. Louis, M.S. Silverberg, C. Collette, G. Fortin, et al. 2009. Genetic variation in the familial mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis. PloS One 4:e7154. Villani, A.C., M. Lemire, E. Louis, M.S. Silverberg, C. Collette, G. Fortin, et al. 2009. Genetic variation in the familial mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis. PloS One 4:e7154.
34.
go back to reference Andersson, E., D. Bergemalm, R. Kruse, G. Neumann, M. D'Amato, D. Repsilber, et al. 2017. Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles. PloS One 12:e0186142. Andersson, E., D. Bergemalm, R. Kruse, G. Neumann, M. D'Amato, D. Repsilber, et al. 2017. Subphenotypes of inflammatory bowel disease are characterized by specific serum protein profiles. PloS One 12:e0186142.
35.
go back to reference Majster, M., R. Lira-Junior, C.M. Höög, S. Almer, and E.A. Boström. 2020. Salivary and serum inflammatory profiles reflect different aspects of inflammatory bowel disease activity. Inflammatory Bowel Diseases 26: 1588–1596.CrossRef Majster, M., R. Lira-Junior, C.M. Höög, S. Almer, and E.A. Boström. 2020. Salivary and serum inflammatory profiles reflect different aspects of inflammatory bowel disease activity. Inflammatory Bowel Diseases 26: 1588–1596.CrossRef
36.
go back to reference Kalla, R., A.T. Adams, D. Bergemalm, S. Vatn, N.A. Kennedy, P. Ricanek, et al. 2021. Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease. Journal of Crohn’s & Colitis 15: 699–708.CrossRef Kalla, R., A.T. Adams, D. Bergemalm, S. Vatn, N.A. Kennedy, P. Ricanek, et al. 2021. Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease. Journal of Crohn’s & Colitis 15: 699–708.CrossRef
37.
go back to reference Lorentz, A., J. Hoppe, H. Worthmann, T. Gebhardt, U. Hesse, J. Bienenstock, et al. 2007. Neurotrophin-3, but not nerve growth factor, promotes survival of human intestinal mast cells. Neurogastroenterology and Motility 19: 301–308.CrossRef Lorentz, A., J. Hoppe, H. Worthmann, T. Gebhardt, U. Hesse, J. Bienenstock, et al. 2007. Neurotrophin-3, but not nerve growth factor, promotes survival of human intestinal mast cells. Neurogastroenterology and Motility 19: 301–308.CrossRef
38.
go back to reference Ballester-López, C., T.M. Conlon, Z. Ertüz, F.R. Greiffo, M. Irmler, S.E. Verleden, et al. 2019. The notch ligand DNER regulates macrophage IFNγ release in chronic obstructive pulmonary disease. eBioMedicine 43: 562–575.CrossRef Ballester-López, C., T.M. Conlon, Z. Ertüz, F.R. Greiffo, M. Irmler, S.E. Verleden, et al. 2019. The notch ligand DNER regulates macrophage IFNγ release in chronic obstructive pulmonary disease. eBioMedicine 43: 562–575.CrossRef
39.
go back to reference Brost, S., R. Koschny, J. Sykora, W. Stremmel, F. Lasitschka, H. Walczak, et al. 2010. Differential expression of the TRAIL/TRAIL-receptor system in patients with inflammatory bowel disease. Pathology, Research and Practice 206: 43–50.CrossRef Brost, S., R. Koschny, J. Sykora, W. Stremmel, F. Lasitschka, H. Walczak, et al. 2010. Differential expression of the TRAIL/TRAIL-receptor system in patients with inflammatory bowel disease. Pathology, Research and Practice 206: 43–50.CrossRef
40.
go back to reference Grabinger, T., K.J. Bode, J. Demgenski, C. Seitz, M.E. Delgado, F. Kostadinova, et al. 2017. Inhibitor of apoptosis protein-1 regulates tumor necrosis factor-mediated destruction of intestinal epithelial cells. Gastroenterology 152: 867–879.CrossRef Grabinger, T., K.J. Bode, J. Demgenski, C. Seitz, M.E. Delgado, F. Kostadinova, et al. 2017. Inhibitor of apoptosis protein-1 regulates tumor necrosis factor-mediated destruction of intestinal epithelial cells. Gastroenterology 152: 867–879.CrossRef
41.
go back to reference Ślebioda, T.J., and Z. Kmieć. 2014. Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease. Mediators of Inflammation 2014:325129. Ślebioda, T.J., and Z. Kmieć. 2014. Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease. Mediators of Inflammation 2014:325129.
42.
go back to reference Cooke, J., H. Zhang, L. Greger, A.L. Silva, D. Massey, C. Dawson, et al. 2012. Mucosal genome-wide methylation changes in inflammatory bowel disease. Inflammatory Bowel Diseases 18: 2128–2137.CrossRef Cooke, J., H. Zhang, L. Greger, A.L. Silva, D. Massey, C. Dawson, et al. 2012. Mucosal genome-wide methylation changes in inflammatory bowel disease. Inflammatory Bowel Diseases 18: 2128–2137.CrossRef
43.
go back to reference Grimstad, T., I.M. Skoie, J. Doerner, K. Isaksen, L. Karlsen, L. Aabakken, et al. 2017. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease. Scandinavian Journal of Gastroenterology 52: 420–424.CrossRef Grimstad, T., I.M. Skoie, J. Doerner, K. Isaksen, L. Karlsen, L. Aabakken, et al. 2017. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease. Scandinavian Journal of Gastroenterology 52: 420–424.CrossRef
44.
go back to reference Boriushkin, E., J.J. Wang, J. Li, M. Bhatta, and S.X. Zhang. 2016. P58IPK suppresses NLRP3 inflammasome activation and IL-1β production via inhibition of PKR in macrophages. Scientific Reports 6: 25013.CrossRef Boriushkin, E., J.J. Wang, J. Li, M. Bhatta, and S.X. Zhang. 2016. P58IPK suppresses NLRP3 inflammasome activation and IL-1β production via inhibition of PKR in macrophages. Scientific Reports 6: 25013.CrossRef
45.
go back to reference Lang, T., J.P.W. Lee, K. Elgass, A.A. Pinar, M.D. Tate, E.H. Aitken, et al. 2018. Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation. Nature Communications 9: 2223.CrossRef Lang, T., J.P.W. Lee, K. Elgass, A.A. Pinar, M.D. Tate, E.H. Aitken, et al. 2018. Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation. Nature Communications 9: 2223.CrossRef
46.
go back to reference Ghimire, L., S. Paudel, L. Jin, and S. Jeyaseelan. 2020. The NLRP6 inflammasome in health and disease. Mucosal Immunology 13: 388–398.CrossRef Ghimire, L., S. Paudel, L. Jin, and S. Jeyaseelan. 2020. The NLRP6 inflammasome in health and disease. Mucosal Immunology 13: 388–398.CrossRef
47.
go back to reference Neurath, M.F. 2017. Current and emerging therapeutic targets for IBD. Nature Reviews: Gastroenterology & Hepatology 14: 269–278. Neurath, M.F. 2017. Current and emerging therapeutic targets for IBD. Nature Reviews: Gastroenterology & Hepatology 14: 269–278.
Metadata
Title
MEFV and NLRP3 Inflammasome Expression Is Attributed to Immature Macrophages and Correlates with Serum Inflammatory Proteins in Crohn´s Disease Patients
Authors
Frida Gorreja
Charles Caër
Stephen T. A. Rush
Sophia K. Forsskål
Anetta Härtlova
Maria K. Magnusson
Elinor Bexe Lindskog
Lars G. Börjesson
Mattias Block
Mary Jo Wick
Publication date
21-02-2022
Publisher
Springer US
Published in
Inflammation / Issue 4/2022
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-022-01647-8

Other articles of this Issue 4/2022

Inflammation 4/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.